Sanofi SA (SNY)
45.40
-0.71
(-1.54%)
USD |
NASDAQ |
Apr 18, 16:00
45.40
0.00 (0.00%)
After-Hours: 20:00
Sanofi Net Income (TTM): 5.859B for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.859B |
| September 30, 2023 | 9.638B |
| June 30, 2023 | 8.980B |
| March 31, 2023 | 8.667B |
| December 31, 2022 | 8.778B |
| September 30, 2022 | 6.911B |
| June 30, 2022 | 7.544B |
| March 31, 2022 | 7.736B |
| December 31, 2021 | 7.369B |
| September 30, 2021 | 14.42B |
| June 30, 2021 | 13.56B |
| March 31, 2021 | 12.04B |
| June 30, 2020 | 12.12B |
| March 31, 2020 | 3.655B |
| December 31, 2019 | 3.089B |
| September 30, 2019 | 3.447B |
| June 30, 2019 | 4.128B |
| March 31, 2019 | 5.135B |
| December 31, 2018 | 5.092B |
| September 30, 2018 | 4.933B |
| June 30, 2018 | 4.131B |
| March 31, 2018 | 4.362B |
| December 31, 2017 | 9.187B |
| September 30, 2017 | 9.909B |
| June 30, 2017 | 9.935B |
| Date | Value |
|---|---|
| March 31, 2017 | 10.10B |
| December 31, 2016 | 5.228B |
| September 30, 2016 | 4.741B |
| June 30, 2016 | 4.682B |
| March 31, 2016 | 4.813B |
| December 31, 2015 | 4.768B |
| September 30, 2015 | 6.075B |
| June 30, 2015 | 5.842B |
| March 31, 2015 | 5.469B |
| December 31, 2014 | 5.800B |
| September 30, 2014 | 5.571B |
| June 30, 2014 | 5.610B |
| March 31, 2014 | 5.129B |
| December 31, 2013 | 4.950B |
| September 30, 2013 | 4.009B |
| June 30, 2013 | 4.317B |
| March 31, 2013 | 5.212B |
| December 31, 2012 | 6.278B |
| September 30, 2012 | 7.652B |
| June 30, 2012 | 8.597B |
| March 31, 2012 | 8.566B |
| December 31, 2011 | 7.860B |
| September 30, 2011 | 6.578B |
| June 30, 2011 | 5.787B |
| March 31, 2011 | 6.510B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
3.089B
Minimum
Dec 2019
14.42B
Maximum
Sep 2021
8.114B
Average
7.736B
Median
Mar 2022
Net Income (TTM) Benchmarks
| AstraZeneca PLC | 5.955B |
| GSK PLC | 6.132B |
| Novo Nordisk A/S | 12.15B |
| Regeneron Pharmaceuticals Inc | 3.954B |
| Inhibrx Inc | -241.36M |